Sandra M. Holley, Ph.D. - Publications

Affiliations: 
Cornell University, Ithaca, NY, United States 
Area:
NMDARs, AMPARs, Huntington's Disease, electrophysiology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lee K, Bakhurin KI, Claar LD, Holley SM, Chong NC, Cepeda C, Levine MS, Masmanidis SC. Gain Modulation by Corticostriatal and Thalamostriatal Input Signals during Reward-Conditioned Behavior. Cell Reports. 29: 2438-2449.e4. PMID 31747611 DOI: 10.1016/j.celrep.2019.10.060  1
2019 Holley SM, Galvan L, Kamdjou T, Dong A, Levine MS, Cepeda C. Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington's Disease Mice. Frontiers in Synaptic Neuroscience. 11: 14. PMID 31139071 DOI: 10.3389/fnsyn.2019.00014  1
2019 Seidlits SK, Liang J, Bierman RD, Sohrabi A, Karam J, Holley SM, Cepeda C, Walthers CM. Peptide-modified, hyaluronic acid-based hydrogels as a 3D culture platform for neural stem/progenitor cell engineering. Journal of Biomedical Materials Research. Part A. PMID 30615255 DOI: 10.1002/jbm.a.36603  1
2018 Holley SM, Galvan L, Kamdjou T, Cepeda C, Levine MS. Striatal GABAergic Interneuron Dysfunction in the Q175 Mouse Model of Huntington's Disease. The European Journal of Neuroscience. PMID 30472747 DOI: 10.1111/ejn.14283  1
2018 Lee K, Holley SM, Shobe JL, Chong NC, Cepeda C, Levine MS, Masmanidis SC. Parvalbumin Interneurons Modulate Striatal Output and Enhance Performance during Associative Learning. Neuron. 99: 239. PMID 30001509 DOI: 10.1016/j.neuron.2018.06.034  1
2018 Donzis EJ, Holley SM, Cepeda C, Levine MS. Neurophysiological Assessment of Huntington's Disease Model Mice. Methods in Molecular Biology (Clifton, N.J.). 1780: 163-177. PMID 29856019 DOI: 10.1007/978-1-4939-7825-0_9  1
2018 Holley SM, Kamdjou T, Reidling JC, Fury B, Coleal-Bergum D, Bauer G, Thompson LM, Levine MS, Cepeda C. Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings. Cns Neuroscience & Therapeutics. PMID 29512295 DOI: 10.1111/cns.12839  1
2017 Reidling JC, Relaño-Ginés A, Holley SM, Ochaba J, Moore C, Fury B, Lau A, Tran AH, Yeung S, Salamati D, Zhu C, Hatami A, Cepeda C, Barry JA, Kamdjou T, et al. Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. Stem Cell Reports. PMID 29233555 DOI: 10.1016/j.stemcr.2017.11.005  1
2017 Lichtenberg NT, Pennington ZT, Holley SM, Greenfield VY, Cepeda C, Levine MS, Wassum KM. Basolateral amygdala to orbitofrontal cortex projections enable cue-triggered reward expectations. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28743727 DOI: 10.1523/JNEUROSCI.0486-17.2017  1
2017 Lee K, Holley SM, Shobe JL, Chong NC, Cepeda C, Levine MS, Masmanidis SC. Parvalbumin Interneurons Modulate Striatal Output and Enhance Performance during Associative Learning. Neuron. 93: 1451-1463.e4. PMID 28334608 DOI: 10.1016/j.neuron.2017.02.033  1
2015 Holley SM, Joshi PR, Parievsky A, Galvan L, Chen JY, Fisher YE, Huynh MN, Cepeda C, Levine MS. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease. Eneuro. 2. PMID 26203463 DOI: 10.1523/ENEURO.0008-14.2015  1
2015 Pappas SS, Darr K, Holley SM, Cepeda C, Mabrouk OS, Wong JM, LeWitt TM, Paudel R, Houlden H, Kennedy RT, Levine MS, Dauer WT. Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons. Elife. 4. PMID 26052670 DOI: 10.7554/eLife.08352  1
2014 Wang N, Gray M, Lu XH, Cantle JP, Holley SM, Greiner E, Gu X, Shirasaki D, Cepeda C, Li Y, Dong H, Levine MS, Yang XW. Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease. Nature Medicine. 20: 536-41. PMID 24784230 DOI: 10.1038/nm.3514  1
2013 Espinosa-Jeffrey A, Barajas SA, Arrazola AR, Taniguchi A, Zhao PM, Bokhoor P, Holley SM, Dejarme DP, Chu B, Cepeda C, Levine MS, Gressens P, Feria-Velasco A, de Vellis J. White matter loss in a mouse model of periventricular leukomalacia is rescued by trophic factors. Brain Sciences. 3: 1461-82. PMID 24961618 DOI: 10.3390/brainsci3041461  1
2013 Cepeda C, Galvan L, Holley SM, Rao SP, André VM, Botelho EP, Chen JY, Watson JB, Deisseroth K, Levine MS. Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 7393-406. PMID 23616545 DOI: 10.1523/JNEUROSCI.2137-12.2013  1
2013 Holley SM, Wang EA, Cepeda C, Jentsch JD, Ross CA, Pletnikov MV, Levine MS. Frontal cortical synaptic communication is abnormal in Disc1 genetic mouse models of schizophrenia. Schizophrenia Research. 146: 264-72. PMID 23481583 DOI: 10.1016/j.schres.2013.02.007  1
2012 Holley SM, Ahmed AH, Srinivasan J, Murthy SE, Weiland GA, Oswald RE, Nowak LM. The loss of an electrostatic contact unique to AMPA receptor ligand binding domain 2 slows channel activation. Biochemistry. 51: 4015-27. PMID 22512472 DOI: 10.1021/bi3001837  1
2010 Cepeda C, Cummings DM, André VM, Holley SM, Levine MS. Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms. Asn Neuro. 2: e00033. PMID 20396376 DOI: 10.1042/AN20090058  1
Show low-probability matches.